Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

ConclusionsOur study showed for the first time that low baseline serum sodium concentration is associated with impaired clinical outcomes in patients with metastatic NSCLC treated with IO. The role of serum sodium concentration in this setting warrants further pre-clinical and clinical investigation.

http://link.springer.com/10.1007/s11523-018-0599-5

Source: Targeted Oncology - October 10, 2018 Category: Cancer & Oncology Source Type: research